Epidemiological features of invasive and noninvasive group A streptococcal disease in the Netherlands, 1992-1996

Eur J Clin Microbiol Infect Dis. 2004 Jun;23(6):434-44. doi: 10.1007/s10096-004-1147-z. Epub 2004 May 26.

Abstract

A prospective, nationwide, laboratory-based surveillance of invasive group A streptococcal infections was conducted in the Netherlands from 1992 through 1996. Clinical and demographic data were obtained and all isolates were T/M typed. All noninvasive group A streptococcal isolates were registered from 1994 through 1996. A total of 880 patients with invasive streptococcal disease were identified. The annual incidence was found to be 2.2 per 100,000. Predominant M types were M1 (21%), M3 (11%), M6 (5%), M12 (5%), and M28 (8%). Particular age and M-type distributions were observed in different clinical entities. The case-fatality rate was 18% overall, but it reached 59% among cases of toxic shock-like syndrome. Older age, necrotizing fasciitis, sepsis without focus, pneumonia, infection with type M1 or M3 strains, and underlying cardiopulmonary disease were associated with fatality. A total of 10,105 patients with noninvasive group A streptococcal disease were registered. These patients differed significantly from patients with invasive disease with regard to age distribution and primary foci of infection.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Analysis of Variance
  • Anti-Bacterial Agents
  • Bacteremia / drug therapy
  • Bacteremia / epidemiology*
  • Bacteremia / microbiology
  • Child
  • Child, Preschool
  • Drug Therapy, Combination / administration & dosage
  • Fasciitis, Necrotizing / drug therapy
  • Fasciitis, Necrotizing / epidemiology*
  • Fasciitis, Necrotizing / microbiology
  • Female
  • Follow-Up Studies
  • Health Surveys
  • Humans
  • Incidence
  • Infant
  • Male
  • Middle Aged
  • Netherlands / epidemiology
  • Probability
  • Prospective Studies
  • Risk Assessment
  • Severity of Illness Index
  • Sex Distribution
  • Streptococcal Infections / drug therapy
  • Streptococcal Infections / epidemiology
  • Streptococcal Infections / microbiology
  • Streptococcus pyogenes / isolation & purification*

Substances

  • Anti-Bacterial Agents